4.5 Article

Viruses are prevalent in non-ventilated hospital-acquired pneumonia

期刊

RESPIRATORY MEDICINE
卷 122, 期 -, 页码 76-80

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.rmed.2016.11.023

关键词

Bacteria; Hospital; Outcomes; Pneumonia; Virus

资金

  1. BJC Healthcare Foundation
  2. Abbott
  3. Alios
  4. Allergam
  5. Astellas
  6. AstraZeneca
  7. Bayer
  8. Cidara
  9. MedCo
  10. Melinta
  11. Merck
  12. Paratek
  13. Roche
  14. Tetraphase
  15. Theravance
  16. Wockhardt

向作者/读者索取更多资源

Background: Hospital-acquired pneumonia arising in non-ventilated patients (NVHAP) is traditionally thought to be caused by bacteria, and little is known about viral etiologies in this syndrome. We sought to describe the prevalence of viruses causing NVHAP and to determine factors independently associated with the isolation of a virus. Methods: We identified patients with NVHAP over one year and reviewed their cultures to determine etiologies. Patients with a viral process were compared to those with either negative cultures or a bacterial infection to determine variables independently associated with the recovery of a virus. Results: Among 174 cases, cultures were positive in 46.0%, with viruses identified in 22.4%. Bacterial pathogens arose 23.6% of subjects. The most common viruses included rhinovirus, influenza, and parainfluenza. We noted no seasonality in the isolation of viral organisms, and most cases of viral NVHAP developed after more than a week length of stay (LOS). Outcomes in viral NVHAP were similar to those with bacterial NVHAP. Patients with viral and bacterial NVHAP were generally similar. Two variables were independently associated with isolation of a virus: a history of coronary artery disease (adjusted odds ratio: 5.16, 95% CI: 1.14-22.44) and a LOS of greater than 10 days prior to NVHAP diagnosis (adjusted odds ratio: 2.97, 95% CI: 1.35-6.51). As a screening test for a virus, neither had a good sensitivity or specificity. Conclusions: Viruses represent a common cause of NVHAP. Clinicians should consider viral diagnostic testing in NVHAP, as this may represent a means to enhance antimicrobial stewardship. (C) 2016 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据